Literature DB >> 16361086

A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence.

Hendrik G Roozen1, Ranne de Waart, Danielle A W M van der Windt, Wim van den Brink, Cor A J de Jong, Ad J F M Kerkhof.   

Abstract

This systematic review summarises evidence of the effectiveness of naltrexone (NTX) and the added value of psychosocial treatment in the maintenance treatment of opioid and alcohol dependence. Studies were selected through a literature search conducted in March 2004. Seven opioid and seventeen alcohol studies were identified. When possible, meta-(regression) analyses were performed. There is lack of evidence about the effectiveness of NTX in the maintenance treatment of opioid dependence. There is evidence for the effectiveness and applicability of NTX in the management of alcohol dependence. The opioid studies combined NTX with a variety of psychosocial interventions, which plagued the evaluation of their value. Concomitant psychosocial interventions used in the alcohol studies were mainly cognitive behavioural, which seems to be more effective than NTX combined with supportive therapy. Available data do not allow firm conclusions regarding the added effect of psychosocial interventions. However, the data suggest that a combination of naltrexone with cognitive behavioural relapse prevention therapy is beneficial in alcohol dependent patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16361086     DOI: 10.1016/j.euroneuro.2005.11.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  23 in total

1.  Maintenance of reinforcement to address the chronic nature of drug addiction.

Authors:  Kenneth Silverman; Anthony DeFulio; Sigurdur O Sigurdsson
Journal:  Prev Med       Date:  2012-06-05       Impact factor: 4.018

2.  Pharmacological Treatment of Youth Substance Use Disorders.

Authors:  Lindsay M Squeglia; Matthew C Fadus; Erin A McClure; Rachel L Tomko; Kevin M Gray
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-04-22       Impact factor: 2.576

Review 3.  A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here.

Authors:  Walter Ling
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-23       Impact factor: 4.147

4.  Clinical guideline for homeless and vulnerably housed people, and people with lived homelessness experience.

Authors:  Kevin Pottie; Claire E Kendall; Tim Aubry; Olivia Magwood; Anne Andermann; Ginetta Salvalaggio; David Ponka; Gary Bloch; Vanessa Brcic; Eric Agbata; Kednapa Thavorn; Terry Hannigan; Andrew Bond; Susan Crouse; Ritika Goel; Esther Shoemaker; Jean Zhuo Jing Wang; Sebastian Mott; Harneel Kaur; Christine Mathew; Syeda Shanza Hashmi; Ammar Saad; Thomas Piggott; Neil Arya; Nicole Kozloff; Michaela Beder; Dale Guenter; Wendy Muckle; Stephen Hwang; Vicky Stergiopoulos; Peter Tugwell
Journal:  CMAJ       Date:  2020-03-09       Impact factor: 8.262

5. 

Authors:  Kevin Pottie; Claire E Kendall; Tim Aubry; Olivia Magwood; Anne Andermann; Ginetta Salvalaggio; David Ponka; Gary Bloch; Vanessa Brcic; Eric Agbata; Kednapa Thavorn; Terry Hannigan; Andrew Bond; Susan Crouse; Ritika Goel; Esther Shoemaker; Jean Zhuo Jing Wang; Sebastian Mott; Harneel Kaur; Christine Mathew; Syeda Shanza Hashmi; Ammar Saad; Thomas Piggott; Neil Arya; Nicole Kozloff; Michaela Beder; Dale Guenter; Wendy Muckle; Stephen Hwang; Vicky Stergiopoulos; Peter Tugwell
Journal:  CMAJ       Date:  2020-10-13       Impact factor: 8.262

6.  Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community.

Authors:  Sandra A Springer; Angela Di Paola; Marwan M Azar; Russell Barbour; Archana Krishnan; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2017-03-10       Impact factor: 4.492

Review 7.  Alcoholic liver disease: treatment.

Authors:  Ki Tae Suk; Moon Young Kim; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

8.  Potent inhibition of alcohol self-administration in alcohol-preferring rats by a κ-opioid receptor antagonist.

Authors:  John R Cashman; Marc R Azar
Journal:  J Pharmacol Exp Ther       Date:  2014-05-09       Impact factor: 4.030

9.  Adoption of injectable naltrexone in U.S. substance use disorder treatment programs.

Authors:  Lydia Aletraris; Mary Bond Edmond; Paul M Roman
Journal:  J Stud Alcohol Drugs       Date:  2015-01       Impact factor: 2.582

Review 10.  The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders.

Authors:  Christopher J Hammond
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2016-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.